Literature DB >> 8738434

Biological phenotype of HIV type 2 isolates correlates with V3 genotype.

J Albert1, P Stålhandske, S Marquina, J Karis, R A Fouchier, E Norrby, F Chiodi.   

Abstract

The biological phenotype of HIV-2 isolates can be divided into two groups, rapid/high and slow/low, based on the ability to infect CD4+ tumor cell lines. Similar differences in the biological phenotype of HIV-1 isolates are largely determined by the charge of two specific amino acids in the V3 loop of the envelope protein gp120. In this study we have sequenced the V3 loop and flanking regions of 14 HIV-2 isolates from Guinea-Bissau and the Ivory Coast and correlated the results to the biological phenotype of the isolates. The sequences were obtained by PCR amplification of DNA from peripheral blood mononuclear cells infected with the different isolates, followed by direct sequencing of the amplified products. Eleven other HIV-2 isolates with known V3 sequence and biological phenotype were also included. Thirteen of the 14 new isolates were classified as subtype A of HIV-2 and one as subtype B. The V3 loop of rapid/high HIV-2 isolates differed significantly from slow/low isolates in that it was more heterogeneous in sequence and had higher net charge. Mutations at two specific amino acid positions (313 and 314), often to positively charged amino acids, were also significantly associated with the rapid/high phenotype. There were no sequence differences between rapid/high and slow/low isolates in the regions that flank the V3 loop. Our findings indicate that there may be a high degree of similarity in the molecular features that underlie the biological phenotypes of HIV-1 and HIV-2 isolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738434     DOI: 10.1089/aid.1996.12.821

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Introduction of human immunodeficiency virus type 2 infection in the Philippines.

Authors:  Prisca Susan Leaño; Seiji Kageyama; Adelfa Espantaleon; Janak Maniar; Masaomi Iwasaki; Dattatray Saple; Namiko Yoshihara; Takashi Kurimura; Dorothy May Agdamag
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells.

Authors:  S M Owen; S Masciotra; F Novembre; J Yee; W M Switzer; M Ostyula; R B Lal
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.

Authors:  N C Grassly; Z Xiang; K Ariyoshi; P Aaby; H Jensen; M Schim van der Loeff; F Dias; H Whittle; J Breuer
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.

Authors:  Pierre Delobel; Marie-Thérèse Nugeyre; Michelle Cazabat; Christophe Pasquier; Bruno Marchou; Patrice Massip; Françoise Barre-Sinoussi; Nicole Israël; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

5.  Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana.

Authors:  Kwc Sagoe; Jaa Mingle; Rk Affram; S Britton; A Dzokoto; A Sonnerborg
Journal:  Ghana Med J       Date:  2008-03

6.  Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.

Authors:  S M Owen; D Ellenberger; M Rayfield; S Wiktor; P Michel; M H Grieco; F Gao; B H Hahn; R B Lal
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

Authors:  Renate R König; Egbert Flory; Stefanie Steidl; Jeanette Neumann; Cheick Coulibaly; Edgar Holznagel; Silke Holzammer; Stephen Norley; Klaus Cichutek
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.

Authors:  Quirina Santos-Costa; Maria Manuel Lopes; Marta Calado; José Miguel Azevedo-Pereira
Journal:  Retrovirology       Date:  2014-11-25       Impact factor: 4.602

10.  A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

Authors:  A McKnight; M T Dittmar; J Moniz-Periera; K Ariyoshi; J D Reeves; S Hibbitts; D Whitby; E Aarons; A E Proudfoot; H Whittle; P R Clapham
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.